These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1113 related articles for article (PubMed ID: 3595669)

  • 1. Cytotoxic chemotherapy of disseminated cutaneous malignant melanoma--a prospective and randomized clinical trial of procarbazine, vindesine and lomustine versus procarbazine, DTIC and lomustine.
    Carmo-Pereira J; Costa FO; Henriques E
    Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1435-9. PubMed ID: 3595669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination cytotoxic chemotherapy with procarbazine, vincristine, and lomustine (POC) in disseminated malignant melanoma: 8 years' follow-up.
    Carmo-Pereira J; Costa FO; Henriques E
    Cancer Treat Rep; 1984 Oct; 68(10):1211-4. PubMed ID: 6525593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of BELD combination chemotherapy (bleomycin, vindesine, CCNU, and DTIC) in advanced malignant melanoma.
    Young DW; Lever RS; English JS; MacKie RM
    Cancer; 1985 May; 55(9):1879-81. PubMed ID: 2579722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective randomized trial in advanced malignant melanoma with cis-platinum, vindesine, and etoposide vs. cis-platinum, vindesine, and lomustine.
    Bajetta E; Buzzoni R; Viviani S; Vaglini M; Nava M; Bonadonna G
    Am J Clin Oncol; 1985 Oct; 8(5):401-5. PubMed ID: 3904398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy of two different dosage dacarbazine-based regimens and two regimens without dacarbazine in metastatic melanoma: a single-centre randomized four-arm study.
    Jelić S; Babovic N; Kovcin V; Milicevic N; Milanovic N; Popov I; Radosavljevic D
    Melanoma Res; 2002 Feb; 12(1):91-8. PubMed ID: 11828263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial.
    Jungnelius U; Ringborg U; Aamdal S; Mattsson J; Stierner U; Ingvar C; Malmström P; Andersson R; Karlsson M; Willman K; Wist E; Bjelkengren G; Westberg R
    Eur J Cancer; 1998 Aug; 34(9):1368-74. PubMed ID: 9849419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of procarbazine, vincristine and lomustine (POC) chemotherapy in metastatic cutaneous malignant melanoma.
    Samuel LM; Harvey VJ; Mitchell PL; Thompson PI; Mak D; Melville P; Evans BD
    Eur J Cancer; 1994; 30A(14):2054-6. PubMed ID: 7857702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy of disseminated melanoma with bleomycin, vincristine, CCNU, and DTIC (BOLD regimen). The Prudente Foundation Melanoma Study Group.
    Cancer; 1989 May; 63(9):1676-80. PubMed ID: 2467736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A phase I-II trial.
    Ringborg U; Jungnelius U; Hansson J; Strander H
    Am J Clin Oncol; 1990 Jun; 13(3):214-7. PubMed ID: 2346126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
    Parasramka S; Talari G; Rosenfeld M; Guo J; Villano JL
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011773. PubMed ID: 28744879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination cytotoxic chemotherapy with CCNU, procarbazine, and vincristine in disseminated cutaneous malignant melanoma: 3 years, followup.
    Carmo-Pereira J; Costa FO; Pimentel P; Henriques E
    Cancer Treat Rep; 1980 Jan; 64(1):143-5. PubMed ID: 7379048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and toxicity of "BELD" polychemotherapy in advanced malignant melanoma.
    Cartei G; Ceschia T; Marsilio P; Clocchiatti L; Fasola G; Morandini G; Galletti D; Sibau A
    Tumori; 1989 Jun; 75(3):229-32. PubMed ID: 2475950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma.
    Thatcher D; Lind M; Morgenstern G; Carr T; Chadwick G; Jones R; Craig P
    Cancer; 1989 Apr; 63(7):1296-302. PubMed ID: 2646005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nine years' experience of BELD combination chemotherapy (bleomycin, vindesine, CCNU and DTIC) for metastatic melanoma.
    Stables GI; Doherty VR; MacKie RM
    Br J Dermatol; 1992 Nov; 127(5):505-8. PubMed ID: 1281672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic malignant melanoma treated with procarbazine, vincristine and lomustine (POC).
    Repetto L; Grimaldi A; Ardizzoni A; Sertoli MR; Rosso R
    Chemioterapia; 1987 Feb; 6(1):63-5. PubMed ID: 3829137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dacarbazine versus dacarbazine-vindesine in disseminated malignant melanoma: a randomized phase II study.
    Ringborg U; Rudenstam CM; Hansson J; Hafström L; Stenstam B; Strander H
    Med Oncol Tumor Pharmacother; 1989; 6(4):285-9. PubMed ID: 2693850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
    Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of metastatic malignant melanoma with dacarbazine, vindesine and cisplatin.
    Pectasides D; Yianniotis H; Alevizakos N; Bafaloukos D; Barbounis V; Varthalitis J; Dimitriadis M; Athanassiou A
    Br J Cancer; 1989 Oct; 60(4):627-9. PubMed ID: 2803936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma.
    Pyrhönen S; Hahka-Kemppinen M; Muhonen T
    J Clin Oncol; 1992 Dec; 10(12):1919-26. PubMed ID: 1280673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma.
    Van Dyk JJ; Falkson G
    Med Pediatr Oncol; 1975; 1(2):107-11. PubMed ID: 1228411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.